Have you ever eat chicken claw? turns out a chicken claw was good for our consumption, as reported previously in detikhealth, chicken claw can improve immunity and prevent cancer. Just like a shark fin, aka claw also contains a lot of chicken legs to coat the joint cartilage.

American Cancer Society has developed a cancer drug made from cartilage. Drugs made from shark fin was quite effective, but difficult to obtain raw materials in large quantities without disturbing the balance of marine life.

In this case if the shark to be protected, then the chicken claw could be an alternative because both contain a lot of cartilage. Chicken claw obviously more readily available because these birds are grown so it is not possible extinction although consumed continuously.

Other Ingredients can be found in shark’s fin and chicken claw is glucosamine and chondroitin, two compounds are efficacious as a natural anti-inflammatory. A study in 1995 proved, two compounds that could alleviate the symptoms of rheumatoid arthritis or osteoarthritis.

Another advantage of a chicken claw than the shark fin is a very high content of kolagennya. Collagen is a type of protein and is widely used in beauty products are widely available on the bones, joints, and the hardened skin on chicken claw.

The protein will give the sensation of feeling a little chewy when cooked in chicken claw is believed to be good for skin health because it can reduce the effects of aging, including skin dull and wrinkled. Quoted from Wisegeek, Wednesday (23/03/2011), collagen is also good for healthy hair and nails, making it suitable for those who want to maintain their physical beauty.

However, not much chicken claw containing meat or muscle which is the main protein source. To get a balanced nutrition, hobbies imbangi eating chicken claw with eating meat, especially the chest which contains more protein and little fat on the skin.

Papaya began to gain a prominent place in the Western medical world after a study proving the efficacy of the plant to ward off cancer. In many cultures, people have learned the benefits of fruits, leaves, until the sap of the plant to treat various diseases.
Researchers University of Florida, Nam Dang, and colleagues in Japan have documented the anticancer effect of papaya which is amazing against various tumor cells that developed in the laboratory, including cervical cancer, breast, liver, lung, and pancreas. The researchers used a similar extract prepared from dried papaya leaves. Papaya proven anticancer effect is much stronger when the cancer cells battered papaya leaf tea in an increasingly large doses.

In a paper published in the Journal of Ethnopharmacology, 17 February, Dang and his research team also documented for the first time that the papaya extract increase the production of an important signal transmitter molecules called cytokines type Th1. Production of these proteins regulate the immune system, plus papaya antitumor effects against various types of cancer, is a treatment strategy that can be used in the immune system to fight cancer.

Papaya extract did not cause toxic effects on normal cells, in contrast to the consequences of other types of cancer therapies, which also mercilessly beat up a healthy cell. Dang, who is also professor of medicine and medical director of Shands Cancer Center Clinical Trials Office at the University of Florida, said the success of papaya extract in the fight against cancer without the toxic effect is consistent with reports from indigenous Australians and his hometown in Vietnam. “Based on what I have heard and seen, all the people who drink this extract showed no toxicity,” he said. “You can consume them in a long time as long as it effectively.”

Scientists apply 10 types of different cancer cell cultures with four kinds of papaya extract that has the power and measure the effect after 24 hours. Papaya reduce tumor growth rate in all cultures.

To identify the mechanism by papaya in inhibiting cancer cell growth in cell culture, the team Dang research focuses on one type of cell to T lymphoma. The results of their research showed that at least there is one mechanism that was launched by the extract of papaya can trigger cell death.

In a similar analysis, the team also investigated the effects of papaya extracts on the production of antitumor molecules, known as cytokines. In this research, papaya increased Th1 type cytokine production, which is important in regulating the immune system. Based on these reasons, the findings of this study increases the possibility of utilization of papaya extract components in conditions associated with immune system, such as inflammation, autoimmune diseases, and cancer in the future.

Bharat B. Aggarwal, a researcher at the Cancer Center M.D. Anderson, University of Texas at Houston, was so convinced of the restorative power of papaya, so he ate a serving of fruit every day. “We know that papaya has a lot of interesting compounds in it,” said Aggarwal, professor of experimental therapeutic department at the cancer center.

One element that is considered beneficial to health is papain, a special enzyme present only in papaya. Not only in the fruit, these enzymes are also present in papaya leaves. “The paper is not excessive,” he said. “This is a good start in identifying the components responsible for anticancer activity.”

Aggarwal expect success in the pawpaw extract reduced the growth of cancerous cells are not stalled limited experiments in the laboratory, but also tested in animals and humans. “I hope that Dr. Dang continue his research. We need people like him to develop that potential,” he said.

Dang and his team have filed a patent processing means for extracting papaya extract through the University of Tokyo. They plan further study to identify specific compounds in papaya extract that is active against cancer cells. Especially for that stage, Dang took Hendrik Luesch, a fellow member of the Shands Cancer Center, as well as professor of medical chemistry.

Experts have discovered a huge potential of tobacco plant that had been getting a bad image because people are used as material for cigarettes that cause millions of cases of cancer worldwide. It turned out that tobacco can be used as a cancer drug chronic lymphoma. Drugs of this tobacco will arrange for the patient’s own immune response against the tumor cells themselves.
The drug is made ​​by using a new approach that changes the tobacco crop was genetically engineered into plants to certain vaccines. Lymphoma is a type of cancer involving cells of the immune system. A doctor from Stanford University in California say that this is the first time a type of plant used to produce proteins to be injected to humans and would be a way to cure cancer without side effects.
The researchers wounding tobacco leaves wrapped with a virus gene to infect these plants, which subsequently produce protein antibodies are also seen in tumor patients. A few days later, the leaves are plucked and pounded a green powder. From the leaves, the anti-body was taken and clarified. Materials are then injected back into the patient. This is the first cancer vaccine from plants have been tested in humans. Vaccines derived from plants have a number of advantages. The vaccine can be developed much faster and much cheaper.

Cervical cancer or cervical cancer caused by Human Papillomavirus Virus (HPV). There are at least 118 different types of HPV is the cause but only 8 types of HPV that are most widely spread in more than 90 percent of cervical cancer cases.
International research team led by Silvia de San Jose of the Catalan Institute of Oncology in Barcelona check the HPV types that contribute to cases of cervical cancer.
This study used data from 10,575 cases of cervical cancer in 38 countries for over 60 years. The study involved cancer cases from Europe, North America, South America, Africa, Asia and Oceania.
The results, published in the Lancet medical journal shows that there are 8 types of HPV responsible for 90 percent of cervical cancer cases. Types of HPV are types 16, 18, 45, 33, 31, 52, 58 and 35.
Researchers also identified several rare species such as HPV types 26, 30, 61, 67, 69, 82 and 91, this type can also cause cancer but the percentage is only about 1 percent worldwide.
Drug manufacturer GlaxoSmithKline and Merck & Co. have made a vaccine against strains of HPV that cause most cervical cancer. Cervical cancer is the second most common cancer suffered by women around the world.
Cervarix vaccine from GSK and Merck’s new Gardasil provides protection against HPV types 16 and 18. HPV immunization will be given to girls who are not yet sexually active, but the price of the vaccine is too expensive so can not be maximally accessible in poor countries.
“Prevention of cervical cancer through a vaccine that is still rational, and these results will help develop a second generation vaccine that can protect some types of HPV,” said De San Jose, as quoted by Reuters on Monday (10/18/2010).